Bayforest Capital’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Buy
+3,240
New +$154K 0.13% 284
2026
Q1
Sell
-2,407
Closed -$222K 994
2025
Q4
$222K Buy
+2,407
New +$230K 0.17% 251
2025
Q2
Sell
-5,491
Closed -$875K 831
2025
Q1
$875K Buy
5,491
+5,277
+2,466% +$955K 0.38% 54
2024
Q4
$39.7K Buy
+214
New +$41.5K 0.05% 504

Other funds holding INSP

Bayforest Capital's INSP Position: Q2 2026 in Review

Bayforest Capital opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 3,240 shares worth $145K. The stake represents 0.13% of the portfolio and ranks #284 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in INSP as recently as Q4 2025.

Bayforest Capital first reported a position in INSP in Q4 2024 and has held it in 4 quarters since. The position peaked at $875K in Q1 2025. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Bayforest Capital held 3,240 shares of Inspire Medical Systems worth $145K as of Q2 2026.
  • Inspire Medical Systems was a new Bayforest Capital position in Q2 2026.
  • Inspire Medical Systems made up 0.13% of Bayforest Capital's portfolio in Q2 2026, its #284 holding.
  • Bayforest Capital first reported a position in Inspire Medical Systems in Q4 2024 and has held it in 4 quarters since.
  • Bayforest Capital's Inspire Medical Systems position peaked at $875K in Q1 2025.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.